Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women
Vermund S, Galbraith M, Ebner S, Sheon A, Kaslow R. Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women. Annals Of Epidemiology 1992, 2: 773-802. PMID: 1342332, DOI: 10.1016/1047-2797(92)90072-x.Peer-Reviewed Original ResearchConceptsPregnant womenClinical outcomesHuman immunodeficiency virus/Anti-Pneumocystis drugsCells/mm3Adverse clinical outcomesHigh-risk womenHuman immunodeficiency virusLarge multicenter studyImmunodeficiency syndrome (AIDS) epidemicAdequate clinical treatmentHealth care servicesClinical decision makingPerinatal transmissionSelective immunosuppressionHIV diseaseImmunosuppressed womenAvailable antiviralsHIV infectionImmunodeficiency syndromeImmunodeficiency virusMulticenter studyVirus/Therapeutic decisionsHigh riskCD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review
Stein D, Korvick J, Vermund S. CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review. The Journal Of Infectious Diseases 1992, 165: 352-363. PMID: 1346152, DOI: 10.1093/infdis/165.2.352.Peer-Reviewed Original ResearchConceptsCell countHuman immunodeficiency virus (HIV) diseaseHuman immunodeficiency virus (HIV) infectionIntercurrent viral infectionPractical clinical perspectiveProgressive infectious processImmunodeficiency virus infectionImportant therapeutic decisionsAIDS CommentaryInfluence of drugsT helperClinical courseHIV infectionSurrogate markerTherapeutic decisionsVirus infectionInfectious processViral infectionCD4Clinical perspectiveEnd stageInfectionNational InstituteVirus diseaseCount